Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01912820
What this trial is testing

Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+4 more
Jonsson Comprehensive Cancer Center 32
Early research (Phase 1)Study completedNCT00005627
What this trial is testing

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute
Not applicableEnded earlyNCT00379119
What this trial is testing

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT00246753
What this trial is testing

Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT00002703
What this trial is testing

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Radiation Oncology Group 390
Testing effectiveness (Phase 2)Study completedNCT01468532
What this trial is testing

Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Early research (Phase 1)Study completedNCT00004029
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 46
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Early research (Phase 1)Ended earlyNCT00005067
What this trial is testing

Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01848067
What this trial is testing

Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Not applicableActive Not RecruitingNCT04624256
What this trial is testing

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 208
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Large-scale testing (Phase 3)Study completedNCT00004124
What this trial is testing

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 983
Not applicableLooking for participantsNCT07468903
What this trial is testing

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Testing effectiveness (Phase 2)Study completedNCT00499408
What this trial is testing

Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)Study completedNCT00561314
What this trial is testing

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionUrinary Incontinence
University College London Hospitals 33
Testing effectiveness (Phase 2)Study completedNCT00080808
What this trial is testing

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 111
Next Page